Early clinical studies from general critically ill populations demonstrated that tightly controlling hyperglycemia with insulin was associated with improved outcomes [102]; however, the subsequent landmark randomized NICE-SUGAR trial showed no benefit of intensive glucose control versus moderate control in the general ICU population [103]. This evidence concerns the gene INS and Hyperglycemia.